BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 28388953)

  • 1. A randomized controlled study on the efficacy of a novel combination vaccine against enzootic pneumonia (Mycoplasma hyopneumoniae) and porcine Circovirus type 2 (PCV2) in the presence of strong maternally derived PCV2 immunity in pigs.
    Tassis PD; Tsakmakidis I; Papatsiros VG; Koulialis D; Nell T; Brellou G; Tzika ED
    BMC Vet Res; 2017 Apr; 13(1):91. PubMed ID: 28388953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
    Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions.
    Jeong J; Park C; Choi K; Chae C
    Vet Microbiol; 2016 Jan; 182():178-86. PubMed ID: 26711046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of a trivalent vaccine mixture against a triple challenge with Mycoplasma hyopneumoniae, PCV2, and PRRSV and the efficacy comparison of the respective monovalent vaccines against a single challenge.
    Oh T; Park KH; Yang S; Jeong J; Kang I; Park C; Chae C
    BMC Vet Res; 2019 Oct; 15(1):342. PubMed ID: 31619295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
    Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
    Park C; Jeong J; Choi K; Chae C
    Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 3 vaccination strategies against porcine reproductive and respiratory syndrome virus,
    Jeong J; Kang I; Kim S; Park KH; Park C; Chae C
    Can J Vet Res; 2018 Jan; 82(1):39-47. PubMed ID: 29382967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Field efficacy study of a novel ready-to-use vaccine against mycoplasma hyopneumoniae and porcine circovirus type 2 in a Greek farm.
    Tzika ED; Tassis PD; Koulialis D; Papatsiros VG; Nell T; Brellou G; Tsakmakidis I
    Porcine Health Manag; 2015; 1():15. PubMed ID: 28405421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of porcine circovirus type 2 and Mycoplasma hyopneumoniae vaccines on dually infected pigs.
    Seo HW; Park SJ; Park C; Chae C
    Vaccine; 2014 May; 32(21):2480-6. PubMed ID: 24631087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Performance parameters and pathogen detection in pig groups differently vaccinated with respect to Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae].
    Tameling A; Könighoff P; Beilage EG; Menrath A; Heimann M; Köhrmann A; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2022 Feb; 50(1):21-29. PubMed ID: 35235980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high and low levels of maternally derived antibodies on porcine circovirus type 2 (PCV2) infection dynamics and production parameters in PCV2 vaccinated pigs under field conditions.
    Feng H; Segalés J; Fraile L; López-Soria S; Sibila M
    Vaccine; 2016 Jun; 34(27):3044-3050. PubMed ID: 27155497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2.
    Kim D; Kim CH; Han K; Seo HW; Oh Y; Park C; Kang I; Chae C
    Vaccine; 2011 Apr; 29(17):3206-12. PubMed ID: 21354247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal vaccination strategy against Mycoplasma hyopneumoniae, porcine reproductive and respiratory syndrome virus, and porcine circovirus type 2 in case of early M. hyopneumoniae infection.
    Yang S; Oh T; Mago J; Iwakuma A; Chae C
    Vet Med Sci; 2020 Nov; 6(4):860-874. PubMed ID: 32462794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
    Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
    BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effects of a single dose of MHYOSPHERE® PCV ID with three commercial porcine vaccine associations against Mycoplasma hyopneumoniae (Mhyo) and porcine circovirus type 2 (PCV2) on piglet growth during the nursery period under field conditions.
    Puig A; Bernal I; Sabaté D; Ballarà I; Montané J; Nodar L; Angelats D; Jordà R
    Vet Res Commun; 2022 Dec; 46(4):1167-1173. PubMed ID: 35829861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
    Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
    Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and
    Yang S; Park SJ; Oh T; Cho H; Chae C
    Can J Vet Res; 2020 Oct; 84(4):272-282. PubMed ID: 33012976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum acute phase response induced by different vaccination protocols against circovirus type 2 and Mycoplasma hyopneumoniae in piglets.
    Hernández-Caravaca I; Gourgues SF; Rodríguez V; Estrada ED; Cerón JJ; Escribano D
    Res Vet Sci; 2017 Oct; 114():69-73. PubMed ID: 28324811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field evaluation of a sing-dose bivalent vaccine of porcine circovirus type 2b and Mycoplasma hyopneumoniae.
    Yang S; Ahn Y; Oh T; Cho H; Park KH; Chae C
    Vet Med Sci; 2021 May; 7(3):755-765. PubMed ID: 33386664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous porcine circovirus type 2 and Mycoplasma hyopneumoniae co-inoculation does not potentiate disease in conventional pigs.
    Sibila M; Fort M; Nofrarías M; Pérez de Rozas A; Galindo-Cardiel I; Mateu E; Segalés J
    J Comp Pathol; 2012; 147(2-3):285-95. PubMed ID: 22522076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.